106 related articles for article (PubMed ID: 28396510)
1. In Vivo Enrichment of Diabetogenic T Cells.
Thelin MA; Kissler S; Vigneault F; Watters AL; White D; Koshy ST; Vermillion SA; Mooney DJ; Serwold T; Ali OA
Diabetes; 2017 Aug; 66(8):2220-2229. PubMed ID: 28396510
[TBL] [Abstract][Full Text] [Related]
2. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
3. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
Wilson SS; DeLuca D
J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cells in type 1 diabetes.
Pugliese A
J Clin Invest; 2017 Aug; 127(8):2881-2891. PubMed ID: 28762987
[TBL] [Abstract][Full Text] [Related]
5. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
6. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
8. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
[TBL] [Abstract][Full Text] [Related]
9. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
10. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
11. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
12. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
13. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
Jaakkola I; Jalkanen S; Hänninen A
Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
15. Optimal T-cell receptor affinity for inducing autoimmunity.
Koehli S; Naeher D; Galati-Fournier V; Zehn D; Palmer E
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17248-53. PubMed ID: 25411315
[TBL] [Abstract][Full Text] [Related]
16. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
[TBL] [Abstract][Full Text] [Related]
17. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
18. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
19. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
20. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
Tisch R; Wang B
Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
